Market Overview – In 2022, the market for minimally invasive surgical devices was estimated to be worth USD 12.9 billion. The market for minimally invasive surgical devices is expected to expand at a compound annual growth rate (CAGR) of 9.20% between 2023 and 2032, from USD 14.06 billion in 2023 to USD 28.483 billion. The Minimally-Invasive Surgery Devices Market is experiencing rapid...

Market Overview – In 2022, the market for ultrasound devices was estimated to be worth USD 10.8 billion. The market for ultrasound devices is expected to expand at a compound annual growth rate (CAGR) of 4.1% between 2023 and 2032, from an estimated USD 11.2 billion in 2023 to USD 15.39 billion by 2032. The Ultrasound Devices Market is witnessing significant growth driven by...

Market Overview – Over the projection period of 2022–2030, the surgical site infection control market is projected to grow at a 5.80% CAGR to reach USD 4969.21 million by 2030. The Post-Surgical Infection Prevention market is gaining momentum as healthcare facilities prioritize patient safety. Surgical site infections pose a significant risk, driving demand for effective control...

Global Gene Expression Analysis Market Overview Gene expression analysis. The market was valued at USD 3.9 billion in 2022. The gene expression analysis market is expected to increase from USD 4.3 billion in 2023 to USD 9.42 billion by 2032, with a compound annual growth rate (CAGR) of 10.3% over the forecast period (2023-2032). The Gene Expression Analysis market is witnessing rapid...

Market Overview – The Pharmaceutical Analytical Testing Outsourcing Market refers to the sector within the pharmaceutical industry where companies outsource their analytical testing needs to specialized service providers. This market has witnessed significant growth in recent years due to the increasing complexity of drug formulations and the stringent regulatory requirements imposed by...

Market Overview – The market for orphan pharmaceuticals was estimated to be worth USD 160.78 billion in 2021 and is expected to increase to USD 355.00 billion by 2030, showing a 9.20% compound annual growth rate (CAGR) between 2022 and 2035. The Orphan Drugs Market is a niche segment of the pharmaceutical industry dedicated to treating rare diseases. These diseases, often affecting a...

The Type 1 diabetes market is anticipated to reach USD 7269.29 million by 2030, with a 7.20% CAGR over the forecast period 2022-2030. The Type-1 Diabetes Treatment Market revolves around addressing the needs of individuals with Type-1 diabetes, a chronic condition where the pancreas produces little or no insulin. As of now, there isn't a cure for Type-1 diabetes, so treatment focuses on...

Market Overview – The albumin market revolves around the production, distribution, and utilization of albumin, a vital protein found in blood plasma. Human serum albumin (HSA) and bovine serum albumin (BSA) are the two primary types used in various medical, pharmaceutical, and biotechnological applications. Albumin serves diverse functions in the body, including maintaining osmotic...

Agricultural Biotechnology Market size is expected to register a CAGR of 8.7% and was valued at USD 215.2 Bn in 2032. The agricultural biotechnology market continues its upward trajectory, driven by rising global food demand and the need for sustainable farming practices. Innovations in genetic engineering, molecular breeding, and bioinformatics are reshaping crop production, enhancing yield,...

The biologics market size was valued at USD 425.5 billion in 2022 and is projected to grow from USD 457.83 Billion in 2023 to USD 710.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6% during the forecast period (2023 - 2030). The biologics market continues its upward trajectory, driven by advancements in biotechnology, rising demand for personalized medicine, and...